Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Twim Corp (290090:KRX), powered by AI.
Twim Corp is currently trading at ₩5,420. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Twim Corp on Alpha Lenz.
Twim Corp's P/E ratio is -14.3.
“Twim Corp trades at a P/E of -14.3 (undervalued) with modest ROE of -4.4%.”
Ask for details →Twim Corp is a biotechnology company specializing in the research, development, and commercialization of innovative health solutions. With a focus on cutting-edge biotechnological advancements, Twim Corp aims to address unmet medical needs across various disease areas. This company is known for leveraging advanced molecular biology techniques to develop novel therapeutics and diagnostic tools. It plays a crucial role in the healthcare sector, impacting areas such as oncology, infectious diseases, and genetic disorders. By collaborating with academic institutions and industry partners, Twim Corp enhances its research capabilities and accelerates the introduction of new products to the market. As an integral part of the biotechnology landscape, Twim Corp contributes significantly to advancing medical research and improving patient outcomes globally. Its commitment to innovation and rigorous scientific standards positions it as a key player in the pursuit of transformative healthcare solutions.
“Twim Corp trades at a P/E of -14.3 (undervalued) with modest ROE of -4.4%.”
Ask for details →Twim Corp (ticker: 290090) is a company listed on KRX in the Technology sector (Software - Application). It has approximately 116 employees. Market cap is $40.3B.
The current price is ₩5,420 with a P/E ratio of -14.32x and P/B of 0.64x.
ROE is -4.36% and operating margin is -19.41%. Annual revenue is $21.0B.